These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27461499)

  • 1. [Klotho and vascular calcification].
    Matsui M; Saito Y
    Clin Calcium; 2016 Aug; 26(8):1157-64. PubMed ID: 27461499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.
    Chen YX; Huang C; Duan ZB; Xu CY; Chen Y
    Kaohsiung J Med Sci; 2019 Jul; 35(7):393-400. PubMed ID: 31001900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of klotho on vascular calcification and endothelial function in chronic kidney disease.
    Vervloet MG; Adema AY; Larsson TE; Massy ZA
    Semin Nephrol; 2014 Nov; 34(6):578-85. PubMed ID: 25498377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
    Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
    Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
    Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification.
    Massy ZA; Drüeke TB
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):405-12. PubMed ID: 23722182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.
    Chen J; Zhang X; Zhang H; Liu T; Zhang H; Teng J; Ji J; Ding X
    Int J Biol Sci; 2016; 12(10):1236-1246. PubMed ID: 27766038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
    Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
    Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.
    Six I; Okazaki H; Gross P; Cagnard J; Boudot C; Maizel J; Drueke TB; Massy ZA
    PLoS One; 2014; 9(4):e93423. PubMed ID: 24695641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
    Cianciolo G; Galassi A; Capelli I; Schillaci R; La Manna G; Cozzolino M
    Curr Vasc Pharmacol; 2018 Jan; 16(2):143-156. PubMed ID: 28294047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.